Cara Therapeutics Inc (NAS:CARA)
$ 0.378 -0.0719 (-15.98%) Market Cap: 20.73 Mil Enterprise Value: -13.94 Mil PE Ratio: 0 PB Ratio: 37.80 GF Score: 35/100

Q1 2022 Cara Therapeutics Inc Earnings Call Transcript

May 09, 2022 / 08:30PM GMT
Release Date Price: $7.45 (-7.34%)
Operator

Good afternoon. My name is Mae, and I will be your conference facilitator. I would like to welcome everyone to Cara Therapeutics First Quarter 2022 Financial Results and Update Conference Call. (Operator Instructions) Please be advised that this call is being recorded.

I would now like to introduce Iris Francesconi, Interim Head of Investor Relations from Cara Therapeutics. Ms. Francesconi, you may begin the call.

Iris Francesconi

Thank you, Mae, and good afternoon. Just after market closed today, we issued a press release detailing our corporate progress and financial results for the first quarter of 2022. The press release can be found on our website at www.caratherapeutics.com. You may also listen to a nice webcast and replay of today's call on the Investors section of the website. Participating in today's call are Chris Posner, Cara's President and Chief Executive Officer; Tom Reilly, Cara's Chief Financial Officer; and Dr. Joana Goncalves, Cara's Chief Medical Officer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot